SN.L - Smith & Nephew plc

LSE - LSE Delayed price. Currency in GBp
1,265.00
-5.00 (-0.39%)
At close: 4:36PM GMT
Stock chart is not supported by your current browser
Previous close1,270.00
Open1,269.00
Bid1,240.00 x 240300
Ask1,300.00 x 53000
Day's range1,258.50 - 1,269.50
52-week range1,173.00 - 1,442.00
Volume1,522,831
Avg. volume3,099,548
Market cap11.049B
Beta0.51
PE ratio (TTM)14.42
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield0.31 (1.72%)
Ex-dividend date2017-10-05
1y target estN/A
  • 2 stocks I’d invest in today for my retirement
    Fool.co.uk4 days ago

    2 stocks I’d invest in today for my retirement

    These two companies could have bright futures.

  • Smith & Nephew plc isn’t the only Footsie growth stock I’d buy on the dips
    Fool.co.uk16 days ago

    Smith & Nephew plc isn’t the only Footsie growth stock I’d buy on the dips

    Medical group Smith & Nephew plc (LON:SN) could be a great FTSE 100 (INDEXFTSE:UKX) buy during the next market correction.

  • Reuters - UK Focus16 days ago

    Smith & Nephew meets lower end of guidance range for 2017

    Artificial hip and knee maker Smith & Nephew scraped into the bottom of its guidance range for 2017, with a 3 percent rise in revenue to $4.77 billion pounds and a 20 basis point increase in its trading ...

  • AstraZeneca plc isn’t the only way to play the world’s ageing population
    Fool.co.uk27 days ago

    AstraZeneca plc isn’t the only way to play the world’s ageing population

    AstraZeneca plc (LON: AZN) may have long-term potential, but could this 'niche' healthcare stock be a better way to play the world's ageing population?

  • Reuters - UK Focuslast month

    Britain's FTSE dips as pound gain weighs on exporters

    The UK's top share index fell for a third straight day as a deepening global sell-off in the dollar strengthened sterling and dented earnings prospects for British companies exposed to the U.S. currency. ...

  • This FTSE 100 stock can help you profit from an ageing population
    Fool.co.uklast month

    This FTSE 100 stock can help you profit from an ageing population

    Bilaal Mohamed sees an increase in demand for this FTSE 100 (INDEXFTSE:UKX) company's products.

  • Globe Newswirelast month

    The Steadman Clinic, SPRI and Smith & Nephew Host Annual Vail Hip Symposium

    The Steadman Clinic (TSC) and the Steadman Philippon Research Institute, (SPRI) have joined with host Smith & Nephew to present the 2018 Vail Hip Symposium, a three-day event beginning Thursday, Jan. 11 at the Westin Riverfront Resort & Spa at Beaver Creek. Dr. Marc J. Philippon, Managing Partner of The Steadman Clinic and Co-Chairman of SPRI and one of the leading hip specialists in the industry, has directed SPRI’s efforts in this event since its inception.

  • Reuters - UK Focus2 months ago

    Ex-ArthroCare CFO gets 4 years in U.S. prison for fraud scheme

    The former chief financial officer of medical device company ArthroCare Corp was sentenced on Friday to more than four years in prison after pleading guilty to participating in what federal prosecutors called a $750 million securities fraud. Michael Gluk, 59, was sentenced by U.S. District Judge Sam Sparks in Austin, Texas, after pleading guilty in June to one count of conspiracy to commit wire and securities fraud, the U.S. Justice Department said.

  • 2 FTSE 100 shares that could make your fortune
    Fool.co.uk2 months ago

    2 FTSE 100 shares that could make your fortune

    Royston Wild looks at two FTSE 100 (INDEXFTSE: UKX) stocks that could make you rich.

  • Smith & Nephew's Rotation Medical Deal Aids Tissue Regen Arm
    Zacks2 months ago

    Smith & Nephew's Rotation Medical Deal Aids Tissue Regen Arm

    Smith & Nephew's (SNN) completion of Rotation Medical acquisition appears highly strategic as this will consolidate the company's position in disruptive technologies and advance its overall growth.

  • Stocks Generating Improved Relative Strength: Smith & Nephew
    Investor's Business Daily3 months ago

    Stocks Generating Improved Relative Strength: Smith & Nephew

    Smith & Nephew shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

  • Smith & Nephew Shows Rising Relative Price Performance; Still Shy Of Key Threshold
    Investor's Business Daily4 months ago

    Smith & Nephew Shows Rising Relative Price Performance; Still Shy Of Key Threshold

    Smith & Nephew shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

  • Reuters - UK Focus4 months ago

    Ex-ArthoCare CEO sentenced to 20 years in U.S. prison for fraud

    The former chief executive of medical device company ArthroCare Corp was sentenced on Friday to 20 years in prison after being convicted of having orchestrated what federal prosecutors called a $750 million securities fraud. Michael Baker, 58, was sentenced by U.S. District Judge Sam Sparks in Austin, Texas after a federal jury in August found him guilty of securities fraud, wire fraud and other charges, the U.S. Justice Department said.

  • Reuters4 months ago

    Under pressure Smith & Nephew to focus on efficiency

    Smith & Nephew (SN.L) said no major surgery is required for the artificial knee and hip maker to deliver shareholder value, even as it reported lacklustre sales that increase pressure on the company reportedly being stalked by activist investor Elliott. Two reports last month said that Paul Singer's U.S. hedge fund had taken a stake in Smith & Nephew, reigniting perennial speculation that it could be acquired by a U.S. rival such as Stryker (SYK.N) or be broken up.

  • Reuters - UK Focus4 months ago

    Under pressure Smith & Nephew to focus on efficiency

    Smith & Nephew (Frankfurt: 502816 - news) said no major surgery is required for the artificial knee and hip maker to deliver shareholder value, even as it reported lacklustre sales that increase pressure on the company reportedly being stalked by activist investor Elliott. Two reports last month said that Paul Singer's U.S. hedge fund had taken a stake in Smith & Nephew, reigniting perennial speculation that it could be acquired by a U.S. rival such as Stryker (Swiss: SYK.SW - news) or be broken up.

  • Reuters - UK Focus4 months ago

    BUZZ-Smith & Nephew: weak FY rev outlook

    ** Smith & Nephew falls as much as 3.5% in decent volume before erasing losses ** Says revenue growth for FY will be at lower end of its 3-4 pct guidance ** Revenue $1.15 bln for the quarter, up 3 pct. ...

  • Reuters4 months ago

    Smith & Nephew to buy Rotation Medical for up to $210 million

    Medical technology group Smith & Nephew (SN.L), which some investors believe should streamline operations to make itself a more attractive takeover target, said on Monday it was buying a U.S. sports injury business for up to $210 million (£159 million). The British company, best known for its replacement hips and knees, will pay an initial $125 million to acquire unlisted Minnesota-based Rotation Medical, plus up to $85 million over the next five years if certain financial targets are hit.

  • Reuters - UK Focus4 months ago

    Smith & Nephew to buy Rotation Medical for up to $210 mln

    LONDON, Oct (Shenzhen: 000069.SZ - news) 23 (Reuters) - Medical technology group Smith & Nephew, which some investors believe should streamline operations to make itself a more attractive takeover target, said on Monday it was buying a U.S. sports injury business for up to $210 million. The British company, best known for its replacement hips and knees, will pay an initial $125 million to acquire unlisted Minnesota-based Rotation Medical, plus up to $85 million over the next five years if certain financial targets are hit. Rotator cuff injuries typically occur in people who repeatedly perform overhead motions, either in sport or in their jobs.

  • Reuters4 months ago

    Mondi drags on FTSE, Provident Financial sinks

    British shares ended the session slightly down on Wednesday after results from paper and packaging firm Mondi disappointed and sub-prime lender Provident Financial sank after a downgrade from Barclays. The FTSE 100 (.FTSE) closed down 0.06 percent at 7,533.81 points with financials and materials firms being the biggest drags on the index. The FTSE has moved a long way already and it looks quite toppy," said Rory McPherson, head of investment strategy at Psigma Investment Management.

  • Reuters - UK Focus4 months ago

    Mondi drags on Britain's FTSE, Provident Financial sinks

    British shares dipped slightly on Wednesday after results from paper and packaging firm Mondi disappointed and sub-prime lender Provident Financial sank after a downgrade from Barclays. The FTSE 100 drifted ...

  • Elliott Said to Build Stake in Smith & Nephew
    Bloomberg Video4 months ago

    Elliott Said to Build Stake in Smith & Nephew

    Oct.11 -- Activist investor Paul Singer is honing in on Europe, building stakes in an engineering and healthcare company. An after hour statement revealed Singer's hedge fund Elliott Management added German engineering firm GEA to its portfolio and according to people familiar with the matter, it also took a stake in the British company Smith & Nephew. Bloomberg's Ruth David reports on "Bloomberg Markets: European Open."

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes